Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Clinical trial NCT03934905 · RECRUITING

Trial details

NCT number: NCT03934905
Sponsor: Texas Tech University Health Sciences Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anthracycline Related Cardiotoxicity in Breast Cancer

Start date: 2022-06-01
Primary completion: 2028-11-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.